Endothelin receptor antagonists: Actions and rationale for their development
- 1 August 1994
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 48 (4) , 625-635
- https://doi.org/10.1016/0006-2952(94)90038-8
Abstract
No abstract availableThis publication has 106 references indexed in Scilit:
- An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogsLife Sciences, 1993
- Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153Life Sciences, 1992
- Kinetic analyses demonstrate that the equilibrium assumption does not apply to [125I]endothelin-1 binding dataLife Sciences, 1992
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Endothelin and structurally related analogs distinguish between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1992
- Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Pituitary site of action of endothelin: Selective inhibition of prolactin release in vitroBiochemical and Biophysical Research Communications, 1990
- Identification and characterization of endothelin converting activity in cultured bovine endothelial cellsBiochemical and Biophysical Research Communications, 1990